Literature DB >> 28384548

Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase.

Jing Tang1, Sanjeev Kumar V Vernekar1, Yue-Lei Chen1, Lena Miller2, Andrew D Huber3, Nataliya Myshakina4, Stefan G Sarafianos5, Michael A Parniak2, Zhengqiang Wang6.   

Abstract

Human immunodeficiency virus (HIV) reverse transcriptase (RT) associated ribonuclease H (RNase H) remains the only virally encoded enzymatic function not clinically validated as an antiviral target. 2-Hydroxyisoquinoline-1,3-dione (HID) is known to confer active site directed inhibition of divalent metal-dependent enzymatic functions, such as HIV RNase H, integrase (IN) and hepatitis C virus (HCV) NS5B polymerase. We report herein the synthesis and biochemical evaluation of a few C-5, C-6 or C-7 substituted HID subtypes as HIV RNase H inhibitors. Our data indicate that while some of these subtypes inhibited both the RNase H and polymerase (pol) functions of RT, potent and selective RNase H inhibition was achieved with subtypes 8-9 as exemplified with compounds 8c and 9c.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  2-hydroxyisoquinoline-1,3-diones; HIV; Inhibitor; RNase H; Reverse transcriptase

Mesh:

Substances:

Year:  2017        PMID: 28384548      PMCID: PMC5539924          DOI: 10.1016/j.ejmech.2017.03.059

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  27 in total

Review 1.  HIV-1 replication.

Authors:  E O Freed
Journal:  Somat Cell Mol Genet       Date:  2001-11

2.  The Sandmeyer reaction.

Authors:  H H HODGSON
Journal:  Chem Rev       Date:  1947-04       Impact factor: 60.622

3.  Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors.

Authors:  R Esnouf; J Ren; C Ross; Y Jones; D Stammers; D Stuart
Journal:  Nat Struct Biol       Date:  1995-04

4.  Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.

Authors:  Kalyan Das; Stefan G Sarafianos; Arthur D Clark; Paul L Boyer; Stephen H Hughes; Eddy Arnold
Journal:  J Mol Biol       Date:  2006-09-15       Impact factor: 5.469

5.  4-Substituted 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as a Novel Class of HIV-1 Integrase Inhibitors.

Authors:  Muriel Billamboz; Virginie Suchaud; Fabrice Bailly; Cedric Lion; Jonas Demeulemeester; Christina Calmels; Marie-Line Andréola; Frauke Christ; Zeger Debyser; Philippe Cotelle
Journal:  ACS Med Chem Lett       Date:  2013-05-17       Impact factor: 4.345

6.  Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.

Authors:  Muriel Billamboz; Fabrice Bailly; Maria Letizia Barreca; Laura De Luca; Jean-François Mouscadet; Christina Calmels; Marie-Line Andréola; Myriam Witvrouw; Frauke Christ; Zeger Debyser; Philippe Cotelle
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

7.  A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity.

Authors:  Michael A Parniak; Kyung-Lyum Min; Scott R Budihas; Stuart F J Le Grice; John A Beutler
Journal:  Anal Biochem       Date:  2003-11-01       Impact factor: 3.365

8.  Novel (2,6-difluorophenyl)(2-(phenylamino)pyrimidin-4-yl)methanones with restricted conformation as potent non-nucleoside reverse transcriptase inhibitors against HIV-1.

Authors:  Petr Šimon; Ondřej Baszczyňski; David Šaman; George Stepan; Eric Hu; Eric B Lansdon; Petr Jansa; Zlatko Janeba
Journal:  Eur J Med Chem       Date:  2016-06-17       Impact factor: 6.514

9.  The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus.

Authors:  Yue-Lei Chen; Jing Tang; Matthew J Kesler; Yuk Y Sham; Robert Vince; Robert J Geraghty; Zhengqiang Wang
Journal:  Bioorg Med Chem       Date:  2011-10-24       Impact factor: 3.641

10.  Inhibitors of HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity.

Authors:  Tatiana Ilina; Krystal Labarge; Stefan G Sarafianos; Rieko Ishima; Michael A Parniak
Journal:  Biology (Basel)       Date:  2012-10-19
View more
  12 in total

1.  Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker.

Authors:  Jing Tang; Ha T Do; Andrew D Huber; Mary C Casey; Karen A Kirby; Daniel J Wilson; Jayakanth Kankanala; Michael A Parniak; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Eur J Med Chem       Date:  2019-02-02       Impact factor: 6.514

2.  Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H.

Authors:  Jayakanth Kankanala; Karen A Kirby; Andrew D Huber; Mary C Casey; Daniel J Wilson; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Eur J Med Chem       Date:  2017-09-28       Impact factor: 6.514

3.  Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H.

Authors:  Zhaoyong Xi; Zhengqiang Wang; Stefan G Sarafianos; Nataliya S Myshakina; Rieko Ishima
Journal:  ACS Infect Dis       Date:  2019-10-02       Impact factor: 5.084

4.  miRNA inhibition by proximity-enabled Dicer inactivation.

Authors:  Hao Yan; Fu-Sen Liang
Journal:  Methods       Date:  2019-05-09       Impact factor: 3.608

5.  4,5-Dihydroxypyrimidine Methyl Carboxylates, Carboxylic Acids, and Carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.

Authors:  Tianyu He; Tiffany C Edwards; Jiashu Xie; Hideki Aihara; Robert J Geraghty; Zhengqiang Wang
Journal:  J Med Chem       Date:  2022-04-04       Impact factor: 8.039

6.  Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.

Authors:  Angela Corona; Valentina Onnis; Alessandro Deplano; Giulia Bianco; Monica Demurtas; Simona Distinto; Yung-Chi Cheng; Stefano Alcaro; Francesca Esposito; Enzo Tramontano
Journal:  Pathog Dis       Date:  2017-08-31       Impact factor: 3.166

Review 7.  Recent Advances in the Development of Integrase Inhibitors for HIV Treatment.

Authors:  Jay Trivedi; Dinesh Mahajan; Russell J Jaffe; Arpan Acharya; Debashis Mitra; Siddappa N Byrareddy
Journal:  Curr HIV/AIDS Rep       Date:  2020-02       Impact factor: 5.071

8.  Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.

Authors:  Lei Wang; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Acc Chem Res       Date:  2019-12-27       Impact factor: 22.384

9.  Design, synthesis and activity of light deactivatable microRNA inhibitor.

Authors:  Hao Yan; Umesh Bhattarai; Yabin Song; Fu-Sen Liang
Journal:  Bioorg Chem       Date:  2018-07-02       Impact factor: 5.275

Review 10.  Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase.

Authors:  Eungi Choi; Jayapal Reddy Mallareddy; Dai Lu; Srikanth Kolluru
Journal:  Future Sci OA       Date:  2018-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.